Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Excerpta Medica. Section 31: Arthritis and Rheumatism |
| Vol/bind | 65 |
| Udgave nummer | 5 |
| Sider (fra-til) | 1213-23 |
| Antal sider | 11 |
| ISSN | 0014-4355 |
| DOI | |
| Status | Udgivet - maj 2013 |
ID: 48462465